• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘的发病率与缓解情况:意大利哮喘自然史的回顾性研究

Incidence and remission of asthma: a retrospective study on the natural history of asthma in Italy.

作者信息

De Marco Roberto, Locatelli Francesca, Cerveri Isa, Bugiani Massimiliano, Marinoni Alessandra, Giammanco Giuseppe

机构信息

Unit of Epidemiology and Medical Statistics, University of Verona, c/o Istituti Biologici II, Strada Le Grazie 8, 37134 Verona, Italy.

出版信息

J Allergy Clin Immunol. 2002 Aug;110(2):228-35. doi: 10.1067/mai.2002.125600.

DOI:10.1067/mai.2002.125600
PMID:12170262
Abstract

BACKGROUND

The knowledge of the natural history of asthma from birth to adulthood could provide important clues for its cause and for the understanding of epidemiologic findings.

OBJECTIVE

This study is aimed at assessing the incidence and remission of asthma from birth to the age of 44 years by using data from 18,873 subjects involved in a large, nationally representative, cross-sectional study carried out in Italy from 1998 through 2000.

METHODS

The onset of asthma was defined as the age at the first attack, and remission was considered present when a subject was neither under treatment nor had experienced an asthma attack in the last 24 months. Person-years and survival techniques were used for the analysis.

RESULTS

The average annual incidence rate for the 1953 to 2000 period was 2.56/1000 persons per year. Incidence peaked in boys less than 10 years of age (4.38/1000 persons per year) and in women 30 years of age or older (3.1/1000 persons per year) and showed a generational increase (incident rate ratio = 2.63 and 95% CI = 2.20-3.12 for 1974-1979 vs 1953-1958 birth cohort). The overall remission rate was 45.8% (41.6% in women and 49.5% in men, P <.001). Asthmatic patients in remission had an earlier age at onset (7.8 vs 15.9 years, P <.001) and a shorter duration of the disease (5.6 vs 16.1 years, P <.001) than patients with current asthma. The probability of remission was strongly (P <.001) and inversely related to the age at onset (62.8% and 15.0% in the <10- and > or =20-years age-at-onset groups, respectively).

CONCLUSION

With respect to its natural history, asthma presents 2 different forms: early-onset asthma, which occurs early in childhood, affects mainly boys, and has a good prognosis, and late-onset asthma, which generally occurs during or after puberty, mainly affects women, and has a poor prognosis. The minority of patients with early-onset asthma who do not remit represents more than 35% of patients with current asthma in the general young adult population.

摘要

背景

了解哮喘从出生到成年的自然病史可为其病因及流行病学研究结果的理解提供重要线索。

目的

本研究旨在利用1998年至2000年在意大利进行的一项大型全国代表性横断面研究中18873名受试者的数据,评估从出生到44岁哮喘的发病率和缓解率。

方法

哮喘发作定义为首次发作的年龄,当受试者既未接受治疗且在过去24个月内也未经历哮喘发作时,则认为处于缓解期。采用人年和生存技术进行分析。

结果

1953年至2000年期间的年均发病率为每年2.56/1000人。发病率在10岁以下男孩(每年4.38/1000人)和30岁及以上女性(每年3.1/1000人)中达到峰值,并呈现代际上升趋势(1974 - 1979年出生队列与1953 - 1958年出生队列相比,发病率比 = 2.63,95%CI = 2.20 - 3.12)。总体缓解率为45.8%(女性为41.6%,男性为49.5%,P < .001)。缓解期的哮喘患者发病年龄较早(7.8岁对15.9岁,P < .001),疾病持续时间较短(5.6年对16.1年,P < .001),与当前哮喘患者相比。缓解的概率与发病年龄呈强烈负相关(发病年龄<10岁和≥20岁组分别为62.8%和15.0%,P < .001)。

结论

就其自然病史而言,哮喘呈现两种不同形式:早发型哮喘,在儿童早期发病,主要影响男孩,预后良好;晚发型哮喘,通常在青春期期间或之后发病,主要影响女性,预后不良。早发型哮喘中未缓解的少数患者占普通年轻成年人群中当前哮喘患者的35%以上。

相似文献

1
Incidence and remission of asthma: a retrospective study on the natural history of asthma in Italy.哮喘的发病率与缓解情况:意大利哮喘自然史的回顾性研究
J Allergy Clin Immunol. 2002 Aug;110(2):228-35. doi: 10.1067/mai.2002.125600.
2
Influence of early life exposures on incidence and remission of asthma throughout life.早期生活暴露对一生当中哮喘发病率及缓解情况的影响。
J Allergy Clin Immunol. 2004 May;113(5):845-52. doi: 10.1016/j.jaci.2004.01.780.
3
The course of asthma: A population-based 10-year study examining asthma remission in children diagnosed with asthma in preschool.哮喘病程:一项基于人群的 10 年研究,旨在探讨学龄前被诊断为哮喘的儿童中哮喘缓解情况。
Pediatr Pulmonol. 2020 Aug;55(8):1924-1935. doi: 10.1002/ppul.24881. Epub 2020 Jun 9.
4
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.
5
Early-life determinants of asthma from birth to age 20 years: a German birth cohort study.从出生到 20 岁的哮喘的生命早期决定因素:一项德国出生队列研究。
J Allergy Clin Immunol. 2014 Apr;133(4):979-88. doi: 10.1016/j.jaci.2013.11.035. Epub 2014 Jan 22.
6
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
7
Seventy Years of Asthma in Italy: Age, Period and Cohort Effects on Incidence and Remission of Self-Reported Asthma from 1940 to 2010.意大利哮喘病70年:1940年至2010年年龄、时期和队列对自我报告哮喘发病率及缓解率的影响
PLoS One. 2015 Oct 6;10(10):e0138570. doi: 10.1371/journal.pone.0138570. eCollection 2015.
8
[Third nationwide survey of childhood asthma in urban areas of China].[中国城市地区第三次全国儿童哮喘调查]
Zhonghua Er Ke Za Zhi. 2013 Oct;51(10):729-35.
9
Asthma incidence, remission, relapse and persistence: a population-based study in southern Taiwan.哮喘的发病率、缓解、复发及持续情况:台湾南部一项基于人群的研究
Respir Res. 2014 Nov 12;15(1):135. doi: 10.1186/s12931-014-0135-9.
10
Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey.男性和女性中报告的哮喘发病率与年龄的差异。欧洲呼吸健康调查数据的回顾性分析。
Am J Respir Crit Care Med. 2000 Jul;162(1):68-74. doi: 10.1164/ajrccm.162.1.9907008.

引用本文的文献

1
Use of Electronic Nicotine Delivery Systems and Age of Asthma Onset Among US Adults and Youths.电子尼古丁传送系统的使用与美国成年人和青少年哮喘发病年龄。
JAMA Netw Open. 2024 May 1;7(5):e2410740. doi: 10.1001/jamanetworkopen.2024.10740.
2
Adverse respiratory outcomes among patients with resolved asthma: matched retrospective cohort study.缓解期哮喘患者的不良呼吸结局:匹配回顾性队列研究。
Br J Gen Pract. 2024 May 30;74(743):e364-e370. doi: 10.3399/BJGP.2023.0271. Print 2024 Jun.
3
A real-world pharmacovigilance study of mepolizumab in the FDA adverse event reporting system (FAERS) database.
一项在FDA不良事件报告系统(FAERS)数据库中进行的美泊利单抗真实世界药物警戒研究。
Front Pharmacol. 2023 Dec 21;14:1320458. doi: 10.3389/fphar.2023.1320458. eCollection 2023.
4
Exogenous female sex steroid hormones and new-onset asthma in women: a matched case-control study.外源性雌性性激素与女性新发哮喘:一项匹配病例对照研究。
BMC Med. 2023 Sep 4;21(1):337. doi: 10.1186/s12916-023-03038-8.
5
[A Study of the Prevalence of Asthma in the General Population in Spain].[西班牙普通人群哮喘患病率研究]
Open Respir Arch. 2023 Apr 17;5(2):100245. doi: 10.1016/j.opresp.2023.100245. eCollection 2023 Apr-Jun.
6
Characteristics of inpatients with atopic asthma in a tertiary center: do age and gender have an influence?三级医疗中心特应性哮喘住院患者的特征:年龄和性别有影响吗?
Multidiscip Respir Med. 2022 Nov 15;17:883. doi: 10.4081/mrm.2022.883. eCollection 2022 Jan 12.
7
Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients.二肽基肽酶-4 抑制剂的使用与 2 型糖尿病患者哮喘发病风险的相关性。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221135320. doi: 10.1177/17534666221135320.
8
Inflammatory Remission in T2 Severe Asthma.T2重度哮喘的炎症缓解
Front Allergy. 2022 May 30;3:923083. doi: 10.3389/falgy.2022.923083. eCollection 2022.
9
Effect of the COVID-19 Lockdown on Asthma Biological Rhythms.新冠疫情封锁对哮喘生物节律的影响。
J Biol Rhythms. 2022 Apr;37(2):152-163. doi: 10.1177/07487304221081730. Epub 2022 Mar 23.
10
Sex Disparities in Asthma Development and Clinical Outcomes: Implications for Treatment Strategies.哮喘发生发展及临床结局中的性别差异:对治疗策略的启示
J Asthma Allergy. 2022 Feb 18;15:231-247. doi: 10.2147/JAA.S282667. eCollection 2022.